登录

研究显示新型UTI疫苗持续有效

Studies Show Continued Efficacy of New UTI Vaccine

GlobeNewswire | 2024-05-05 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


SAN ANTONIO, May 04, 2024 (GLOBE NEWSWIRE) -- Abstracts being presented at the American Urological Association's Annual Meeting discuss a new urinary tract infection (UTI) treatment as well as the UTI implications of weight management drugs. Researchers will present their study findings covering important updates on UTI in San Antonio, Texas, from May 3 to 6.

圣安东尼奥,2024年5月4日(环球通讯社)--美国泌尿外科协会年会上发表的摘要讨论了一种新的尿路感染(UTI)治疗方法以及体重管理药物对UTI的影响。研究人员将于5月3日至6日在德克萨斯州圣安东尼奥展示他们的研究结果,涵盖UTI的重要更新。

Wai Lee, MD, assistant professor of urology and director of Female Pelvic Medicine and Reconstructive Surgery at Northwell Health in Long Island, NY, moderated a virtual press session with the abstract authors, providing key insights into their research. “Fifty percent of women develop a urinary tract infection in their lifetime and a quarter will experience recurrent infections.

纽约长岛Northwell Health泌尿外科助理教授兼女性盆腔医学和重建外科主任Wai Lee医学博士主持了一场与抽象作者的虚拟新闻发布会,为他们的研究提供了重要见解。“50%的女性在一生中会患上尿路感染,四分之一的女性会反复感染。

Treating this can be challenging for the patient and for providers,” said Dr. Lee. “We’re excited to look at a longevity study on a new vaccination for UTI as well as research on the potential UTI risks of a popular weight management drug that can alter the body’s metabolism and the amount of sugar in the urinary tract.” The following abstracts are covered in the moderated panel: Evaluating the Safety and Effectiveness of Uromune® Bacterial Vaccine over a 9-Year Period in the UK: A Study on Managing Recurrent Urinary Tract Infections in Men and Women in the Initial CohortSemaglutide Utilization in Weight Management and its Implications for Urinary Tract Infections and Urolithiasis  A recording of the panel discussion is available to all press registrants.

治疗这对患者和提供者来说都是一个挑战,”李博士说。“我们很高兴看到一项关于UTI新疫苗的长寿研究,以及一种流行的体重管理药物的潜在UTI风险研究,这种药物可以改变身体的新陈代谢和泌尿道中的糖量。”以下摘要包含在主持人小组中:评估英国9年期间Uromune®细菌疫苗的安全性和有效性:一项关于在体重管理的初始队列中管理男性和女性反复尿路感染的研究及其对尿路感染和尿石症的影响小组讨论的记录可供所有新闻注册人使用。

Fill out the registration form on the website to be added to the virtual programming: https://www.auanet.org/AUA2024/register/press-registration NOTE TO REPORTERS: Presenting authors and moderators are available to discuss their findings. To arrange an interview with an expert, please.

在网站上填写登记表以添加到虚拟编程:https://www.auanet.org/AUA2024/register/press-registration记者注意:提交作者和主持人可以讨论他们的发现。请安排与专家的面谈。

推荐阅读

Kidney Int:突破性小分子药物c407治疗遗传性肾病综合症的初步结果

MedSci 2024-05-19 06:11

如何预防阿尔茨海默病:以疫苗为例

Forbes 2024-05-19 04:50

华东医药:旗下3款“重磅进口”医美产品“国内临床”取得新进展

医美部落 2024-05-19 00:04

GlobeNewswire

8167篇

最近内容 查看更多

NASDAQ:NARI:Kessler Topaz Meltzer&Check,LLP通知投资者对Inari Medical,股份有限公司提起的证券集体诉讼

27 分钟前

Intercept提供了新数据,证明OCA-苯扎贝特联合治疗对2024年消化道疾病周治疗六个月后ALP和代谢结果的影响

3 小时前

Athira Pharma宣布拟议解决股东衍生诉讼

18 小时前

产业链接查看更多

所属赛道

生物制品-疫苗